List of contributors |
|
ix | |
1 Cancer epidemiology |
|
1 | (40) |
|
|
|
1 | (1) |
|
1.2 Theoretical framework |
|
|
1 | (2) |
|
1.2.1 Global cancer epidemiology |
|
|
1 | (1) |
|
1.2.2 Related factors to cancer |
|
|
2 | (1) |
|
|
3 | (4) |
|
1.3.1 Cancer susceptibility |
|
|
3 | (1) |
|
1.3.2 Spontaneous mutations |
|
|
3 | (1) |
|
|
4 | (1) |
|
|
4 | (1) |
|
1.3.5 Chronic inflammation |
|
|
5 | (2) |
|
|
7 | (9) |
|
|
7 | (1) |
|
1.4.2 Environmental pollutants |
|
|
8 | (2) |
|
|
10 | (1) |
|
1.4.4 Carcinogenesis by the process of food |
|
|
11 | (2) |
|
1.4.5 Supplement and multivitamins |
|
|
13 | (1) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (1) |
|
1.4.9 Overweight and obesity |
|
|
15 | (1) |
|
|
16 | (1) |
|
1.6 Cancer factors according to affected body site |
|
|
17 | (16) |
|
1.6.1 Head and neck cancer |
|
|
17 | (1) |
|
1.6.2 Respiratory system cancer |
|
|
17 | (2) |
|
1.6.3 Digestive system cancer |
|
|
19 | (6) |
|
1.6.4 Urinary system cancer |
|
|
25 | (2) |
|
1.6.5 Reproductive system cancer |
|
|
27 | (2) |
|
1.6.6 Central nervous system cancer |
|
|
29 | (1) |
|
1.6.7 Hematological neoplasia |
|
|
30 | (2) |
|
1.6.8 Challenges and policies |
|
|
32 | (1) |
|
|
33 | (1) |
|
|
33 | (1) |
|
|
33 | (8) |
2 Molecular and therapeutic bases of cancer |
|
41 | (58) |
|
|
|
|
41 | (2) |
|
2.1.1 Hallmarks of cancer |
|
|
42 | (1) |
|
2.2 Grow promotion and cell death suppression |
|
|
43 | (6) |
|
2.2.1 The Interplay of oncogenes and tumor suppression genes |
|
|
43 | (5) |
|
2.2.2 Posttranslational modifications |
|
|
48 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
|
49 | (1) |
|
2.4 Replicative immortality and telomere dysfunctions |
|
|
50 | (1) |
|
2.5 Mechanisms of cell death: cell cycle checkpoints and DNA damage response |
|
|
51 | (1) |
|
2.5.1 Cell cycle checkpoints |
|
|
51 | (1) |
|
2.5.2 Cell death suppression |
|
|
52 | (1) |
|
2.6 Invasion and metastases |
|
|
52 | (7) |
|
2.6.1 Molecular drivers of metastasis |
|
|
53 | (1) |
|
|
54 | (4) |
|
|
58 | (1) |
|
2.7 Metabolic reprograming in cancer |
|
|
59 | (5) |
|
2.7.1 Mechanisms of cancer metabolic reprograming |
|
|
60 | (1) |
|
2.7.2 Oncogenes and tumor suppressor genes in metabolism reprograming |
|
|
60 | (1) |
|
2.7.3 Cell signalling pathways in metabolism reprograming |
|
|
61 | (1) |
|
2.7.4 Cancer-producing factors in metabolism reprograming |
|
|
61 | (1) |
|
2.7.5 Reactive oxygen species in metabolism reprograming |
|
|
61 | (1) |
|
2.7.6 Metabolic plasticity of cancer: metabolic heterogeneity in cancer cells and stroma |
|
|
62 | (1) |
|
2.7.7 Cancer stem cells metabolism |
|
|
63 | (1) |
|
2.7.8 Metabolic reprograming in metastasis |
|
|
63 | (1) |
|
|
64 | (2) |
|
|
66 | (2) |
|
2.9.1 Obesity and hyperinsulinemia |
|
|
67 | (1) |
|
2.10 Epigenetic of cancer |
|
|
68 | (2) |
|
2.10.1 Epigenetic mechanisms |
|
|
68 | (1) |
|
2.10.2 Epigenetic in cancer |
|
|
69 | (1) |
|
2.10.3 Inducers of epigenetic alterations |
|
|
69 | (1) |
|
2.10.4 Epigenetic heterogeneity in cancer |
|
|
70 | (1) |
|
2.10.5 Epigenetic and metabolism interplay in cancer |
|
|
70 | (1) |
|
2.11 Cancer and the circadian clock |
|
|
70 | (1) |
|
|
71 | (11) |
|
2.12.1 Precision medicine |
|
|
71 | (2) |
|
2.12.2 Stem cell transplant |
|
|
73 | (1) |
|
|
74 | (1) |
|
2.12.4 Conventional treatment |
|
|
75 | (2) |
|
|
77 | (1) |
|
|
77 | (5) |
|
2.13 New paradigms of old ideas |
|
|
82 | (1) |
|
2.13.1 A social perspective of cancer |
|
|
83 | (1) |
|
|
83 | (1) |
|
|
84 | (1) |
|
|
84 | (15) |
3 Macronutrients and micronutrients in cancer prevention and treatment |
|
99 | (26) |
|
|
|
|
99 | (1) |
|
3.2 Macronutrients in cancer |
|
|
99 | (9) |
|
|
100 | (1) |
|
|
101 | (3) |
|
|
104 | (4) |
|
|
108 | (10) |
|
|
109 | (1) |
|
3.3.2 Vitamin B1 (thiamine) |
|
|
109 | (1) |
|
3.3.3 Vitamin B9 (folate and folic acid) |
|
|
110 | (1) |
|
3.3.4 Vitamin B12 (cyanocobalamin) |
|
|
111 | (1) |
|
3.3.5 Vitamin C (ascorbic acid) |
|
|
112 | (1) |
|
|
113 | (1) |
|
|
114 | (1) |
|
|
115 | (1) |
|
|
116 | (1) |
|
|
117 | (1) |
|
|
118 | (1) |
|
|
118 | (7) |
4 Phytochemicals in cancer treatment |
|
125 | (36) |
|
|
|
|
125 | (1) |
|
|
126 | (26) |
|
|
126 | (1) |
|
|
127 | (3) |
|
|
130 | (2) |
|
|
132 | (2) |
|
|
134 | (2) |
|
|
136 | (2) |
|
|
138 | (2) |
|
|
140 | (2) |
|
|
142 | (2) |
|
4.2.10 Epigallocatechin-3-gallate |
|
|
144 | (2) |
|
|
146 | (2) |
|
|
148 | (2) |
|
|
150 | (2) |
|
|
152 | (1) |
|
|
153 | (8) |
5 Medicinal plants as potential functional foods or resources for obtaining anticancer activity metabolites |
|
161 | (34) |
|
|
|
|
|
|
161 | (1) |
|
5.2 Medicinal plants with anticancer potential |
|
|
162 | (27) |
|
|
162 | (1) |
|
5.2.2 Cancerina (Semialarium mexicanum (Miers) Mennenga or Hippocratea excelsa) |
|
|
163 | (2) |
|
5.2.3 Kalanchoe genus: Kalanchoe flammea, Kalanchoe tubiflora, Kalanchoe daigremontiana, and Kalanchoe pinnata |
|
|
165 | (1) |
|
5.2.4 Moringa (Moringa oleifera) |
|
|
166 | (2) |
|
5.2.5 Neem (Azadirachta indica) |
|
|
168 | (2) |
|
5.2.6 Ganoderma (Ganoderma lucidum) |
|
|
170 | (1) |
|
5.2.7 Amla (Emblica officinalis) |
|
|
171 | (2) |
|
5.2.8 Quince (Cydonia oblonga) |
|
|
173 | (2) |
|
5.2.9 Noni (Morinda citrifolia) |
|
|
175 | (1) |
|
5.2.10 Cuachalalate (Amphipterygium adstringens) |
|
|
176 | (1) |
|
5.2.11 Cow's tongue (Sansevieria roxburghiana) |
|
|
177 | (2) |
|
5.2.12 Muicle (Justicia spicigera) |
|
|
179 | (1) |
|
5.2.13 Cat's claw (Uncaria tomentosa) |
|
|
180 | (1) |
|
5.2.14 Pink lapacho (Tabebuia avellanedae) |
|
|
181 | (2) |
|
5.2.15 Chamomile (Matricaria chamomilla) |
|
|
183 | (2) |
|
5.2.16 African cabbage, spider tuft, or cat's whiskers (Cleome gynandra) |
|
|
185 | (2) |
|
5.2.17 The devil's staff (Oplopanax horridus) |
|
|
187 | (1) |
|
5.2.18 Hedgehog (Sisymbrium officinale) |
|
|
188 | (1) |
|
|
189 | (1) |
|
|
189 | (1) |
|
|
190 | (5) |
Index |
|
195 | |